Hans Hull, Chief Business Officer: Pliant Therapeutics PLRX Sell · Filed 23/07/19

Trade details

Type: Insider sale
Amount: $323,045.37
Shares · price: 17,937 sh · $18.01 a share
Held after: 219,183 sh
Stock: Pliant Therapeutics PLRX
Person: Hans HullChief Business Officer
Trade date: 23/07/17
Filed: 23/07/19
Days to filing: 2 days

Sold 7.6% of holdings

Share of holding sold: 7.6%

Pliant Therapeutics trades, last 26 weeks

What else happened in Pliant Therapeutics around then

Filed or reported within 30 days of the trade day · 23/06/17~23/08/16

Hans Hull's recent trades

Hans HullChief Business Officer
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$178.5K
15,936 sh
$178.5K
Filed 25/01/22
Traded 25/01/17
Hans HullChief Business Officer
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$114.4K
9,900 sh
$114.4K
Filed 24/07/12
Traded 24/07/10
Hans HullChief Business Officer
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$168.6K
9,786 sh
$168.6K
Filed 24/01/19
Traded 24/01/17
Hans HullChief Business Officer
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$401.2K
20,050 sh
$401.2K
Filed 23/08/07
Traded 23/08/04
Hans HullChief Business Officer
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$261.4K
13,069 sh
$261.4K
Filed 23/08/07
Traded 23/08/03